Cannabix Technologies delivers Marijuana Breath Test Hardware to Omega Laboratories Inc.

Core Insights - Cannabix Technologies Inc. has initiated the phased commercialization of its Cannabix Marijuana Breath Test (MBT) by delivering multiple units to Omega Laboratories in Ohio, focusing on the detection of delta-9-tetrahydrocannabinol (Δ9-THC) in breath samples [1][2] Group 1: Product and Technology - The MBT hardware includes Cannabix's proprietary Breath Collection Unit (BCU) and Breath Cartridges (BC), designed for the recent use detection of Δ9-THC, unlike traditional methods that can detect THC long after consumption [1][2] - The initial shipment consists of 200 Breath Cartridges and several BCUs, supporting the integration of breath testing into Omega's lab testing protocols [2] Group 2: Partnership and Collaboration - Cannabix and Omega are collaborating to implement the MBT with select key clients and are ramping up to meet demand [2] - The partnership includes efforts in manufacturing, marketing, distribution, support, and logistics for the MBT [2] Group 3: Company Background - Omega Laboratories has over twenty years of experience in forensic drug testing and holds multiple federal and international certifications for its facility [3] - Omega's Laboratory Developed Test Method for testing Δ9-THC analytes has been validated in an ISO/IEC 17025 accredited laboratory environment [4]